PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BKY | Ann: Berkeley to Commence International Arbitration against Spain | 11/04/24 | 2 | 682 | |||
|
|||||||
BKY | Ann: Half Year Accounts | 13/03/24 | 0 | 209 | |||
|
|||||||
BKY | Ann: Permitting update | 15/02/24 | 5 | 3.1K | |||
|
|||||||
BKY | Ann: Quarterly Report December 2023 | 30/01/24 | 0 | 374 | |||
|
|||||||
BKY | Ann: Change of Director's Interest Notice x2 | 02/01/24 | 0 | 217 | |||
|
|||||||
BKY | Ann: Notification of cessation of securities - BKY | 02/01/24 | 0 | 181 | |||
|
|||||||
BKY | Ann: Report on Payments to Governments | 21/12/23 | 0 | 243 | |||
|
|||||||
BKY | Ann: Constitution | 21/11/23 | 0 | 278 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |